Abstract
COPHELA (Cooperation in Quality Assurance for Pharmacy Education and Training between Europe and Latin America), a collaborative project between the European Union (EU) and Latin America, will produce on-line courses for the master degree in pharmacy. The program runs from 2019 through 2021. It is funded by the Erasmus+ program of the Education, Audio-visual and Culture Executive Agency (EACEA) of the European Commission. The partners are EU and Latin American universities. These are accompanied by associated partners from EU and Latin American universities, as well as from governmental and non-governmental organizations, such as pharmacy chambers and educational associations. The project is coordinated by the University of Granada, Spain (first author of this paper). It will produce distance learning master degree courses in a dozen fields of specialized pharmaceutical science education and practice, ranging from patient care to industrial pharmacy. This paper describes the design of the project and is intended to evoke constructive comments. It also represents a call for the recruitment of additional associated partners.
Highlights
The target group and the ultimate beneficiaries of the COPHELA project are the populations of the Latin American countries
There will be an improvement in the healthcare of the Latin American population, following the amelioration of pharmaceutical care, based on the upgrade of pharmaceutical specialization in community and hospital pharmacies
The Latin American pharmaceutical industry will benefit by providing employees with the tools required for future changes in the industry, such as the change from a chemistry-based industry producing small molecules to a biotechnology-based industry producing large therapeutic proteins
Summary
In light of the evolving situation in pharmacy specialization in Latin America, the COPHELA project proposes to produce distant learning tools for master degrees in pharmacy specialization.These will be published in Spanish, Portuguese and/or English, and will be available primarily for theLatin American market and in the EU.This COPHELA project is a follow-on to three previous EU-funded projects: PHARMINE (Pharmacy Education in Europe) [1,2], and the derivatives of PHARMINE viz PHAR-QA (Quality Assurance in European Pharmacy Education and Training) [3,4], and PHAR-IN (Competences for industrial pharmacy practice in biotechnology) [5,6].All three projects centered on: The competences for fundamental and specialized pharmacy practice (community, hospital and industry)The education and training tools necessary to produce the competences cited previously in (1) above, andThe harmonization of competences, and the education and training tools necessary, in the EU member states.The purpose of the three previous projects was to adapt pharmacy education in the EU to the on-going evolution in practice. In light of the evolving situation in pharmacy specialization in Latin America, the COPHELA project proposes to produce distant learning tools for master degrees in pharmacy specialization. These will be published in Spanish, Portuguese and/or English, and will be available primarily for the. There is a substantial transformation in industrial pharmacy in research and development, production, etc This accompanies the shift in therapeutics from small chemical drug molecules to large protein biosimilars. The development of the generic drug market with the consequential changes in marketing, regulatory affairs, etc., is another example of the evolution in practice
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
